S100A4 and hepatocellular carcinoma: Although there is no study confirming the relationship between TGFβI and HCC, recently in a study by Sun H et al. [14], they also mentioned that S100A4 can activate HCC metastasis, which lays the foundation for the future clinical application of TGFβI and S100A4 in HCC.